CD147, The Ancillary protein of MCT4, as marker for prognosis and clinical outcome in primary clear cell renal cell Carcinoma and Metastasis

CD147, The Ancillary protein of MCT4, as marker for prognosis and clinical outcome in primary clear cell renal cell Carcinoma and Metastasis

Just as previously demonstrated for MCT4, CD147 is proposed to be associated with tumor progression and metastasis in clear cell renal cell carcinoma (ccRCC) and therefore might represent a promising target for therapeutic intervention and a marker for prognosis and patient outcome.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical therapeutics 2015-08, Vol.37 (8), p.e75-e76
Hauptverfasser: Fisel, P, Stühler, V, Winter, S, Rausch, S, Hennenlotter, J, Nies, A.T, Stenzl, A, Scharpf, M, Fend, F, Kruck, S, Bedke, J, Schwab, M, Schaeffeler, E
Format: Artikel
Sprache:eng
Schlagworte:
Internal Medicine
Medical Education
Metastasis
Protein expression
Proteins
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Just as previously demonstrated for MCT4, CD147 is proposed to be associated with tumor progression and metastasis in clear cell renal cell carcinoma (ccRCC) and therefore might represent a promising target for therapeutic intervention and a marker for prognosis and patient outcome.
ISSN:0149-2918
1879-114X
DOI:10.1016/j.clinthera.2015.05.218